Begacestat clinical trials
Also written GSI-953.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses begacestat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses begacestat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953CompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00441987Written as GSI-953
- Study Evaluating The Coadministration of Begacestat And DonepezilCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00959881Written as Begacestat
- Study Evaluating GSI-953 in Healthy Young and Alzheimer's PatientsCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00479219Written as GSI-953
Codes
What other systems call begacestat · ClinicalTrials.gg INT005412
- MeSH (NLM) C539549begacestatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3666C56BBUBEGACESTATConfirmed FDA, NLM, Wikidata
- Wikidata Q27074993begacestatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76054BegacestatOne source FDA
- DrugBank DB12263One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C539549 | begacestat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3666C56BBU | BEGACESTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27074993 | begacestat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76054 | Begacestat | One source FDA |
| DrugBank | DB12263 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.